University of Oxford s R21/Matrix-M Malaria Vaccine Receives Regulatory Clearance for Ghana Use miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority.
New Oxford University Malaria vaccine receives regulatory approval in Ghana modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Oxford s R21/Matrix-MTM Malaria Vaccine dailyguidenetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyguidenetwork.com Daily Mail and Mail on Sunday newspapers.
An African country, Ghana has become the first country in the world to approve the use of R21/Matrix-M malaria vaccine developed by the University of Oxford and manufactured by the Serum Institute of India. Ghana's Food and Drugs Authority licensed the use of the University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)-manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax's adjuvant technology.